CA
RMD icon

Continuum Advisory’s ResMed RMD Stock Holding History

Continuum Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.02K Buy
+36
New +$7.46K ﹤0.01% 1372
2025
Q2 		– Sell
-2
Closed -$448 – 1319
2025
Q1 		$448 Hold
2
– – ﹤0.01% 1583
2024
Q4 		$457 Hold
2
– – ﹤0.01% 1752
2024
Q3 		$463 Buy
+2
New +$447 ﹤0.01% 1801

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Continuum Advisory's RMD Position: Q2 2026 in Review

Continuum Advisory opened a new position in ResMed (RMD) in Q2 2026: 36 shares worth $7.02K. The stake represents ﹤0.01% of the portfolio and ranks #1372 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in RMD as recently as Q1 2025.

Continuum Advisory first reported a position in RMD in Q3 2024 and has held it in 4 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Continuum Advisory held 36 shares of ResMed worth $7.02K as of Q2 2026.
  • ResMed was a new Continuum Advisory position in Q2 2026.
  • ResMed made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1372 holding.
  • Continuum Advisory first reported a position in ResMed in Q3 2024 and has held it in 4 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.